KCT0001293
Completed
未知
Early response assessment of induction chemotherapy in AML patients using F-18 fluorodeoxythymidine (FLT) positron emission tomography (PET)/computed tomogrpahy (CT)
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Diseases of the blood and blood -forming organs and certain disorders involving the immune mechanism
- Sponsor
- The Catholic University of Korea, St. Vincent's Hospital
- Enrollment
- 13
- Status
- Completed
- Last Updated
- 7 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Acute myeloid leukemia patients who is receiving induction chemotherapy
- •adults over 20 years of age
- •Persones who signed informed consents
Exclusion Criteria
- •Beast feeding
Outcomes
Primary Outcomes
Not specified
Similar Trials
Unknown
Phase 2
A Phase II study of induction chemotherapy S-1 and CDDP in patients with FDG-PET positive N2 disease of non-small cell lung cancer.JPRN-C000000358Fukushima Medical University25
Completed
Phase 2
Study to Evaluate Induction Chemotherapy Using Docetaxel, Cisplatin and Fluorouracil in Concurrence With Intensity-modulated Radiotherapy for Local Recurrent Nasopharyngeal Carcinoma (NPC)Nasopharyngeal CarcinomaNCT01326559Hong Kong Nasopharyngeal Cancer Study Group Limited33
Completed
Phase 2
Evaluation of treatment outcome of induction chemotherapy and then Neoadjuvant chemoradiotherapy and surgery in locally advanced rectal cancerIRCT20200420047139N1Shahid Beheshti University of Medical Sciences30
Terminated
Not Applicable
Assessing the role of Positron Emission Tomography (PET) scanning to assess early response to treatment in advanced breast cancer.ACTRN12612001044819Alfred Foundation5
Active, not recruiting
Phase 2
Induction Chemotherapy Followed by Surgery for Locally Advanced Head and Neck CancerHead and Neck CancerNCT02760667George Washington University20